Quantcast

Latest Rhinitis Stories

2009-05-19 00:00:00

Schering-Plough Assumes Exclusive Worldwide Marketing Rights for Mometasone Furoate/Formoterol Combination for Asthma and COPD KENILWORTH, N.J., May 19 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced changes to its global collaboration with Novartis for the development and commercialization of fixed-dose combination therapies for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The changes will result in Schering-Plough assuming...

2009-05-13 04:00:00

OXFORD, England, May 13 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated a phase II clinical development programme for its ragweed allergy therapy. The treatment for allergic rhino-conjunctivitis caused by ragweed pollen is based on Circassia's ToleroMune(R) technology, which has previously achieved successful phase II results in patients with cat allergies. Ragweed is one of the leading causes of allergic...

2009-05-11 02:00:00

LEEDS and LONDON, May 11 /PRNewswire/ -- - New Hayfever Relief Product Based on Acupressure Points Now Available in UK Stores & Widely Available on the Internet - With Photo Hayfever was unheard of only 200 years ago, however, it's believed that it now affects as many as 1 in 4 people in the UK. For those who do suffer with hayfever, it's either complete misery with symptoms such as reduced concentration, runny nose and itchy eyes throughout the day or the need for drug...

2009-05-04 13:01:00

Neti Pots Show Increase In Searches, Social Media "Chatter," As Consumers Seek Protection Ideas Above and Beyond CDC Recommendations MADISON, Wis., May 4 /PRNewswire/ -- Add nose washing to the steps that consumers are looking to take -- in addition to frequent hand washing and coughing in a tissue -- in an effort to avoid infection with the flu. According to data from Google Insights For Search, "neti pot" increased as a search term some 15-20% last week, with New York and California in...

2009-04-29 02:39:00

ANTONY, France, April 29 /PRNewswire-FirstCall/ -- Stallergenes S.A. announces the release of the first year outcome of its phase IIb/III clinical trial (VO 57.07) on a sublingual house dust mite desensitization tablet. "We are very pleased with the outcome of this study, which is the first large study to ever demonstrate the efficacy of house dust mites allergen in treating perennial allergic rhinitis. Furthermore, the unexpected quick onset of action and the good safety profile are...

2009-04-27 20:57:01

Children with allergies and asthma may benefit from an allergy evaluation, a U.S. allergist advises. Dr. Maya Jerath of the University of North Carolina at Chapel Hill School of Medicine says controlling allergy symptoms can prevent some of the common complications of untreated allergies like sinusitis and ear infections. Some sufferers seek relief with supplements like vitamin C or zinc, Jerath said. These supplements may help with colds, but there are no studies showing they work for...

2009-04-21 04:00:00

OXFORD, England, April 21 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced today that it has initiated a phase II clinical study of its ToleroMune(R) technology in allergy patients with asthma. The trial builds on positive phase II results that demonstrated the potential clinical benefits of ToleroMune allergy therapy, and extends clinical investigations to those with allergy-associated asthma. The lastest study, which is underway in...

2009-04-16 06:00:00

First Selective TLR8 Agonist to Advance for Treatment of Allergy SAN DIEGO, April 16 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and inflammatory diseases, announced today that it has initiated a Phase I clinical trial of VTX-1463, a selective intranasal TLR8 agonist for the treatment of allergic rhinitis. The objectives of this trial will be to...

2009-04-02 08:00:00

- TV Host Explains How Talking to a Pharmacist Helped Her Manage Her Congestion so She Can Get Back to Her Busy Schedule - WASHINGTON, D.C., April 2 /PRNewswire/ -- Mom, actress and allergy sufferer Alison Sweeney knows first hand how symptoms like congestion can make juggling a busy career and family life even more challenging. That's why she's teamed up with the American Pharmacists Association (APhA) and McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. to launch Behind the...

2009-03-23 11:45:11

Alleviating springtime allergies begins with avoiding pollen, if possible, a U.S. doctor advises. Dr. Catherine Monteleone, a board-certified allergist at the University of Medicine and Dentistry of New Jersey, suggests keeping car and home windows closed and, if necessary, the air conditioner on. If you have to be outside, wear sunglasses to shield your eyes from pollen and do activities later in the day, because pollen is released early, Monteleone says in a statement. When you return...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related